After three years of hard fought litigation, Kessler Topaz Meltzer & Check, LLP, along with co-lead counsel,secured a $250 million settlement in a groundbreaking insider trading case against Defendants Valeant Pharmaceutical International, Inc., its former CEO Michael Pearson, billionaire hedge...
Read more >